Panelists discuss how integrating both intravenous (IV) and subcutaneous (SubQ) therapies in oncology centers requires adaptable staffing, data-driven workflow planning, and thoughtful pilot ...
Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, reimbursement complexities, and insufficient economic incentives slow the ...
A 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous ...
Various types of nanoscale drug delivery systems (DDSs) have been developed for therapeutic and/or diagnostic applications. However, most systems have been designed for intravenous or intramuscular ...
Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...
The subcutaneous space offers an attractive and accessible site for cell transplantation. However, its clinical utility is often hindered by insufficient vascularization. This study evaluated the ...
Nucala (mepolizumab) is a brand-name subcutaneous injection that comes in different forms. Depending on which form you’re prescribed, you or your doctor will administer the injection. Nucala injection ...
The Chosun Ilbo on MSN
MSD's Keytruda subcutaneous form approved, marking 1-minute anticancer drug era
A subcutaneous (SC) immune anticancer drug that can be administered in 1–2 minutes by injection into the skin has been newly approved in South Korea. MSD’s immune anticancer drug ‘Keytruda’, widely ...
A 40-year-old woman with type 1 diabetes mellitus (T1DM) who injected insulin into her abdomen developed a firm subcutaneous mass in the right lower quadrant. Pathology after surgical excision showed ...
Subcutaneous injection is a vital technique in mouse-based biomedical research. Compared to other injections, the subcutaneous method poses fewer technical challenges and reduces acute toxicity risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results